CLX - Clorox Co-The Stock Price, Fair Value and News

140.60USD+0.18 (+0.13%)Market Closed as of 09 May 2024, 09:34 am ET

Market Summary

USD140.60+0.18

Market Closedas of 09 May 2024, 09:34 am

0.13%

CLX Alerts

Big jump in Earnings (Y/Y)

Losses in recent quarter

CLX Stock Price

View Fullscreen

CLX RSI Chart

CLX Valuation

Market Cap

17.4B

Price/Earnings (Trailing)

72.68

Price/Sales (Trailing)

2.42

EV/EBITDA

28.64

Price/Free Cashflow

30.6

CLX Price/Sales (Trailing)

CLX Profitability

EBT Margin

4.99%

Return on Equity

94.12%

Return on Assets

4.13%

Free Cashflow Yield

3.27%

CLX Fundamentals

CLX Revenue

Revenue (TTM)

7.2B

Rev. Growth (Yr)

-5.27%

Rev. Growth (Qtr)

-8.84%

CLX Earnings

Earnings (TTM)

240.0M

Earnings Growth (Yr)

75.83%

Earnings Growth (Qtr)

-154.84%

Breaking Down CLX Revenue

52 Week Range

119.56169.87

(Low)(High)

Last 7 days

0.6%

Last 30 days

-2.7%

Last 90 days

-8.9%

Trailing 12 Months

-16.5%

How does CLX drawdown profile look like?

CLX Financial Health

Current Ratio

0.9

Debt/Equity

9.73

Debt/Cashflow

0.32

CLX Investor Care

Dividend Yield

3.19%

Dividend/Share (TTM)

4.72

Shares Dilution (1Y)

0.46%

Diluted EPS (TTM)

1.94

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	7.2B	0	0	0
2023	7.2B	7.4B	7.0B	7.3B
2022	7.1B	7.1B	7.0B	7.1B
2021	7.5B	7.3B	7.2B	7.1B
2020	6.4B	6.7B	7.1B	7.5B
2019	6.3B	6.2B	6.2B	6.1B
2018	6.1B	6.1B	6.2B	6.2B
2017	5.9B	6.0B	6.0B	6.0B
2016	5.7B	5.8B	5.8B	5.9B
2015	5.6B	5.7B	5.7B	5.7B
2014	5.5B	5.5B	5.5B	5.6B
2013	5.5B	5.5B	5.5B	5.5B
2012	5.4B	5.4B	5.4B	5.5B
2011	5.2B	5.2B	5.3B	5.3B
2010	5.3B	5.2B	5.2B	5.2B
2009	5.4B	5.5B	5.4B	5.4B
2008	0	5.3B	5.3B	5.4B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Clorox Co-The

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 28, 2024	williams christopher j	acquired	32,459	153	212	-
Mar 28, 2024	parker paul gray	acquired	13,014	153	85.00	-
Mar 28, 2024	banse amy	acquired	26,181	153	171	-
Mar 14, 2024	hyder chris t	sold (taxes)	-6,369	151	-42.00	group president - health & hyg
Mar 14, 2024	grier stacey	sold (taxes)	-6,369	151	-42.00	evp - executive chief of staff
Dec 29, 2023	parker paul gray	acquired	13,118	142	92.00	-
Dec 14, 2023	hilt angela c	sold (taxes)	-8,672	142	-61.00	evp - chief legal officer
Dec 11, 2023	reynolds eric h	sold (taxes)	-17,221	140	-123	evp - chief operating officer
Dec 11, 2023	jacobsen kevin b	sold (taxes)	-11,900	140	-85.00	evp - chief financial officer
Dec 11, 2023	grier stacey	sold (taxes)	-17,781	140	-127	evp - chief growth & str ofc

Which funds bought or sold CLX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	ANCHOR CAPITAL ADVISORS LLC	reduced	-26.05	-633,511	2,442,840	0.06%
May 07, 2024	WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC	reduced	-0.87	68,264	1,128,420	0.03%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	reduced	-40.87	-2,464,340	4,286,010	-%
May 07, 2024	Bedel Financial Consulting, Inc.	added	0.04	25,010	361,244	0.06%
May 07, 2024	Headlands Technologies LLC	new	-	412,172	412,172	0.10%
May 07, 2024	Choate Investment Advisors	new	-	263,502	263,502	0.01%
May 07, 2024	PRIMORIS WEALTH ADVISORS, LLC	new	-	3,342,700	3,342,700	2.67%
May 07, 2024	NIXON PEABODY TRUST CO	new	-	203,483	203,483	0.02%
May 07, 2024	Williams Jones Wealth Management, LLC.	unchanged	-	14,864	216,344	-%
May 07, 2024	Donoghue Forlines LLC	new	-	275,139	275,139	0.08%

Are Funds Buying or Selling CLX?

Are funds buying CLX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CLX

No. of Funds

Unveiling Clorox Co-The's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	12.28%	15,228,898	SC 13G/A
Jan 25, 2024	blackrock inc.	8.2%	10,119,551	SC 13G/A
Jan 25, 2024	state street corp	6.78%	8,410,519	SC 13G/A
Feb 09, 2023	vanguard group inc	12.28%	15,151,580	SC 13G/A
Feb 06, 2023	state street corp	7.17%	8,844,196	SC 13G/A
Jan 31, 2023	blackrock inc.	7.5%	9,267,422	SC 13G/A
Feb 14, 2022	state street corp	6.71%	8,240,920	SC 13G/A
Feb 09, 2022	vanguard group inc	11.80%	14,500,034	SC 13G/A
Feb 01, 2022	blackrock inc.	8.8%	10,774,842	SC 13G/A
Feb 12, 2021	state street corp	5.89%	7,426,780	SC 13G

Recent SEC filings of Clorox Co-The

View All Filings

Date Filed	Form Type	Document
Apr 30, 2024	8-K	Current Report
Apr 30, 2024	10-Q	Quarterly Report
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading

Peers (Alternatives to Clorox Co-The)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	389.6B	84.1B	5.79%	7.39%	25.75	4.63	3.82%	5.63%
CL	76.7B	19.8B	6.57%	15.92%	29.37	3.88	7.71%	63.39%
EL	46.5B	15.3B	-10.91%	-35.62%	70.18	3.03	-3.25%	-39.29%
CHD	26.1B	5.9B	5.21%	11.30%	33.47	4.39	8.05%	89.02%
CLX	17.4B	7.2B	-2.70%	-16.46%	72.68	2.42	0.53%	224.32%
COTY	9.5B	6.1B	-2.33%	-7.08%	43.11	1.55	13.69%	13.11%
ELF	9.0B	890.1M	-2.60%	86.42%	69.22	10.06	79.24%	176.22%
MID-CAP
IPAR	3.8B	1.3B	-10.43%	-11.76%	27.17	2.85	15.88%	-0.05%
NWL	3.3B	8.0B	8.19%	-18.12%	-11.33	0.42	-10.08%	-121.80%
HIMS	2.6B	959.4M	-18.28%	14.18%	-1.1K	2.7	55.65%	96.05%
HELE	2.4B	2.0B	-6.42%	4.38%	13.94	1.17	-3.26%	17.67%
SMALL-CAP
EPC	1.9B	2.3B	6.18%	-14.58%	15.56	0.85	1.98%	28.45%
ACU	154.9M	190.6M	-5.24%	63.30%	8.4	0.81	-2.98%	477.15%
GROV	55.7M	259.3M	-6.47%	238.30%	-1.29	0.21	-19.36%	50.71%
UG	37.1M	10.9M	4.94%	-20.34%	14.36	3.41	-14.28%	0.46%

Clorox Co-The News

Latest updates

Clorox Co-The Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-8.8%	1,814	1,990	1,386	2,019	1,915	1,715	1,740	1,801	1,809	1,691	1,806	1,802	1,781	1,842	1,916	1,983	1,783	1,449	1,506	1,627	1,551
Gross Profit	-11.5%	766	866	532	862	800	620	626	668	649	558	670	668	774	837	920	929	832	639	663	734	673
S&GA Expenses	-6.5%	301	322	276	329	311	282	261	244	233	241	236	260	237	269	238	279	269	210	211	217	216
R&D Expenses	0%	32.00	32.00	29.00	38.00	35.00	33.00	32.00	34.00	31.00	34.00	33.00	45.00	32.00	40.00	32.00	42.00	39.00	34.00	30.00	38.00	34.00
EBITDA Margin	42.7%	0.10*	0.07*	0.07*	0.08*	0.07*	0.13*	0.12*	0.13*	0.13*	0.09*	0.12*	0.16*	-	-	-	-	-	-	-	-	-
Interest Expenses	-15.4%	22.00	26.00	21.00	21.00	24.00	23.00	22.00	37.00	21.00	23.00	25.00	25.00	25.00	24.00	25.00	25.00	24.00	25.00	25.00	25.00	24.00
Income Taxes	-80.0%	8.00	40.00	4.00	56.00	-36.00	28.00	29.00	25.00	48.00	21.00	42.00	1.00	-	71.00	109	85.00	56.00	50.00	55.00	51.00	53.00
Earnings Before Taxes	-130.9%	-42.00	136	29.00	237	-245	130	116	129	200	93.00	185	101	-59.00	332	526	395	297	235	258	292	240
EBT Margin	132.5%	0.05*	0.02*	0.02*	0.03*	0.02*	0.08*	0.08*	0.09*	0.08*	0.05*	0.08*	0.12*	-	-	-	-	-	-	-	-	-
Net Income	-154.8%	-51.00	93.00	22.00	176	-211	99.00	85.00	101	150	69.00	142	97.00	-61.00	259	415	310	241	185	203	241	187
Net Income Margin	204.2%	0.03*	0.01*	0.01*	0.02*	0.01*	0.06*	0.06*	0.07*	0.06*	0.03*	0.06*	0.10*	-	-	-	-	-	-	-	-	-
Free Cashflow	25.7%	127	101	-4.00	346	285	167	132	256	166	124	-11.00	284	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-1.7%	5,805	5,908	5,991	5,945	5,818	6,045	6,153	6,158	6,322	6,190	6,274	6,334	6,441	6,855	6,777	6,213	5,850	5,459	5,397	5,116	5,162
Current Assets	-7.9%	1,661	1,804	1,911	1,828	1,745	1,622	1,763	1,725	1,869	1,741	1,820	1,829	1,962	2,103	2,144	2,020	1,750	1,303	1,266	1,305	1,393
Cash Equivalents	-38.3%	219	355	518	367	246	170	280	186	243	196	214	324	497	737	867	879	505	174	157	113	180
Inventory	2.9%	674	655	710	696	735	741	755	755	803	818	785	752	688	609	534	454	457	514	504	512	556
Net PPE	-1.7%	1,292	1,314	1,317	1,345	1,315	1,322	1,322	1,334	1,312	1,298	1,301	1,302	1,251	1,221	1,176	1,103	1,047	1,052	1,034	1,034	1,000
Goodwill	-1.8%	1,229	1,252	1,246	1,252	1,250	1,553	1,547	1,558	1,572	1,565	1,566	1,575	1,574	1,803	1,793	208	1,568	1,588	1,585	1,591	1,589
Liabilities	-2.5%	5,550	5,690	5,860	5,557	5,646	5,554	5,657	5,429	5,746	5,699	5,727	5,742	5,503	5,475	5,466	5,305	5,155	4,904	4,847	4,557	4,381
Current Liabilities	-8.7%	1,846	2,022	2,228	1,917	1,996	1,878	2,010	1,784	2,643	2,596	2,639	2,056	1,819	1,738	1,516	1,418	1,794	1,513	1,458	1,440	1,261
Long Term Debt	0.0%	2,480	2,479	2,478	2,477	2,476	2,476	2,475	2,474	1,887	1,886	1,885	2,484	2,483	2,483	2,781	2,780	2,288	2,288	2,287	2,287	2,286
LT Debt, Current	-	-	-	-	-	-	-	-	-	600	600	899	300	300	300	-	-	-	-	-	-	-
LT Debt, Non Current	0.0%	2,480	2,479	2,478	2,477	2,476	2,476	2,475	2,474	1,887	1,886	1,885	2,484	2,483	2,483	2,781	2,780	2,288	2,288	2,287	2,287	2,286
Shareholder's Equity	-58.3%	91.00	218	131	220	172	491	496	729	576	491	547	592	938	1,380	1,311	908	695	555	550	559	781
Retained Earnings	-85.9%	34.00	241	299	583	415	782	832	1,048	951	949	1,027	1,036	1,086	1,302	3,840	3,567	3,398	3,292	3,241	3,150	3,004
Additional Paid-In Capital	2.0%	1,270	1,245	1,246	1,245	1,232	1,207	1,193	1,202	1,195	1,180	1,166	1,186	1,190	1,176	1,146	1,137	1,111	1,062	1,043	1,046	1,033
Accumulated Depreciation	0.3%	2,800	2,792	2,768	2,705	2,672	2,621	2,575	2,530	2,510	2,466	2,422	2,382	2,351	2,319	2,270	2,224	2,203	2,185	2,156	2,150	2,125
Shares Outstanding	0.1%	124	124	124	124	124	124	123	123	123	123	123	126	-	-	-	-	-	-	-	-	-
Minority Interest	-0.6%	164	165	168	168	169	170	170	173	176	178	179	181	195	196	196	-	-	-	-	-	-
Float	-	-	-	-	-	-	17,300	-	-	-	21,400	-	-	-	25,300	-	-	-	19,000	-	-	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	19.0%	182	153	20.00	430	341	209	178	335	229	181	41.00	383	264	246	383	740	308	227	271	389	154
Share Based Compensation	62.5%	26.00	16.00	13.00	13.00	29.00	21.00	10.00	8.00	19.00	16.00	9.00	-2.00	17.00	22.00	13.00	13.00	18.00	13.00	6.00	9.00	16.00
Cashflow From Investing	-15.2%	-38.00	-33.00	-23.00	-81.00	-55.00	-42.00	-45.00	-62.00	-55.00	-56.00	-56.00	-111	-83.00	-107	-151	-107	-47.00	-56.00	-42.00	-70.00	-49.00
Cashflow From Financing	-7.3%	-278	-259	155	-227	-211	-280	-35.00	-326	-128	-143	-92.00	-447	-420	-277	-247	-262	77.00	-155	-183	-386	-91.00
Dividend Payments	-0.7%	148	149	149	146	146	146	145	143	143	143	142	138	140	140	140	134	133	133	133	122	123
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	25.00	300	305	200	100	23.00	30.00	85.00	110	346	72.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

CLX Income Statement

2024-03-31

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 1,814	$ 1,915	$ 5,190	$ 5,370
Cost of products sold	1,048	1,115	3,026	3,324
Gross profit	766	800	2,164	2,046
Selling and administrative expenses	301	311	899	854
Advertising costs	215	206	566	523
Research and development costs	32	35	93	100
Loss on divestiture	240	0	240	0
Pension settlement charge	0	0	171	0
Goodwill, trademark and other asset impairments	0	445	0	445
Interest expense	22	24	69	69
Other (income) expense, net	(2)	24	3	54
Earnings (losses) before income taxes	(42)	(245)	123	1
Income tax expense (benefit)	8	(36)	52	21
Net earnings (losses)	(50)	(209)	71	(20)
Less: Net earnings attributable to noncontrolling interests	1	2	7	7
Net earnings (losses) attributable to Clorox	$ (51)	$ (211)	$ 64	$ (27)
Net earnings (losses) per share attributable to Clorox
Basic net earnings (losses) per share (in dollars per share)	$ (0.41)	$ (1.71)	$ 0.52	$ (0.22)
Diluted net earnings (losses) per share (in dollars per share)	$ (0.41)	$ (1.71)	$ 0.52	$ (0.22)
Weighted average shares outstanding (in thousands)
Basic (in shares)	124,249	123,649	124,133	123,512
Diluted (in shares)	124,249	123,649	124,721	123,512
Comprehensive income (loss)	$ 154	$ (205)	$ 409	$ (39)
Less: Total comprehensive income attributable to noncontrolling interests	1	2	7	7
Total comprehensive income (loss) attributable to Clorox	$ 153	$ (207)	$ 402	$ (46)

CLX Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Jun. 30, 2023
Current assets
Cash and cash equivalents	$ 219	$ 367
Receivables, net	673	688
Inventories, net	674	696
Prepaid expenses and other current assets	95	77
Total current assets	1,661	1,828
Property, plant and equipment, net of accumulated depreciation and amortization of $2,800 and $2,705, respectively	1,292	1,345
Operating lease right-of-use assets	379	346
Goodwill	1,229	1,252
Trademarks, net	539	543
Other intangible assets, net	149	169
Other assets	556	462
Total assets	5,805	5,945
Current liabilities
Notes and loans payable	111	50
Current operating lease liabilities	82	87
Accounts payable and accrued liabilities	1,653	1,659
Income taxes payable	0	121
Total current liabilities	1,846	1,917
Long-term debt	2,480	2,477
Long-term operating lease liabilities	347	310
Other liabilities	853	825
Deferred income taxes	24	28
Total liabilities	5,550	5,557
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2024 and June 30, 2023; and 124,186,844 and 123,820,022 shares outstanding as of March 31, 2024 and June 30, 2023, respectively	131	131
Additional paid-in capital	1,270	1,245
Retained earnings	34	583
Treasury stock, at cost: 6,554,617 and 6,921,439 shares as of March 31, 2024 and June 30, 2023, respectively	(1,189)	(1,246)
Accumulated other comprehensive net (loss) income	(155)	(493)
Total Clorox stockholders’ equity	91	220
Noncontrolling interests	164	168
Total stockholders’ equity	255	388
Total liabilities and stockholders’ equity	$ 5,805	$ 5,945

About Clorox Co-The

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. It sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The Clorox Company was founded in 1913 and is headquartered in Oakland, California.

CEO	Ms. Linda Rendle
WEBSITE	thecloroxcompany.com
INDUSTRY	Household Products
EMPLOYEES	8700

Clorox Co-The Frequently Asked Questions

What is the ticker symbol for Clorox Co-The? What does CLX stand for in stocks?

CLX is the stock ticker symbol of Clorox Co-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Clorox Co-The (CLX)?

As of Wed May 08 2024, market cap of Clorox Co-The is 17.44 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLX stock?

You can check CLX's fair value in chart for subscribers.

What is the fair value of CLX stock?

You can check CLX's fair value in chart for subscribers. The fair value of Clorox Co-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Clorox Co-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CLX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Clorox Co-The a good stock to buy?

The fair value guage provides a quick view whether CLX is over valued or under valued. Whether Clorox Co-The is cheap or expensive depends on the assumptions which impact Clorox Co-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLX.

What is Clorox Co-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, CLX's PE ratio (Price to Earnings) is 72.68 and Price to Sales (PS) ratio is 2.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Clorox Co-The's stock?

In the past 10 years, Clorox Co-The has provided 0.071 (multiply by 100 for percentage) rate of return.